Prestige Consumer Healthcare Inc. (PBH) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$46.40

From 52W high−35.95%

Volume1.92M

Market cap$2.13B

P/E (TTM)12.5x

P/S (TTM)1.9x

Div yield—

Key dataSep 18, 2026

Open

$46.40

From 52W high

−35.95%

Volume

1.92M

Market cap

$2.13B

ValuationView details →

P/E (Fwd)

9.6x

EV/EBITDA

13.1x

P/E (TTM)

12.5x

RSI (14)

31.5

MomentumView details →

1D Return

−3.23%

YTD Return

−26.15%

SummaryUpdated Jun 1, 2026

Prestige Consumer Healthcare Inc. (NYSE:PBH) is a consumer healthcare company founded in 1996 and headquartered in Tarrytown, New York. The company develops, manufactures, markets, and distributes over-the-counter (OTC) health and personal care products primarily in the United States and internationally. Originally known as Prestige Brands Holdings Inc., the company changed its name to Prestige Consumer Healthcare Inc. in August 2018 and went public in February 2005. Today, Prestige operates as a diversified portfolio company with a collection of trusted consumer healthcare brands spanning multiple therapeutic categories.

Ask drillr about Prestige Consumer Healthcare Inc. →

ValuationView details →

P/E (Fwd)

9.6x

P/E (TTM)

12.5x

EV/EBITDA

13.1x

EV/Sales

3.7x

P/S (TTM)

1.9x

P/B (TTM)

1.1x

ProfitabilityView details →

Gross Margin

53.26%

Net Margin

15.57%

EBITDA Margin

28.30%

ROE (TTM)

8.97%

ROA (TTM)

3.77%

Asset Turnover

0.27x

GrowthView details →

Revenue YoY

−1.36%

EPS YoY

−16.51%

FCF YoY

−12.13%

Revenue CAGR 3Y

−1.17%

EPS CAGR 3Y

−3.38%

EBITDA YoY

−13.04%

MomentumView details →

1D Return

−3.23%

YTD Return

−26.15%

1Y Return

−27.80%

RSI (14)

31.5

vs 50D SMA

−9.77%

vs 200D SMA

−19.03%

Capital & dividendView details →

Debt/Equity

1.08x

Current Ratio

3.23x

Quick Ratio

1.99x

Div Yield

—

Div Rate

—

Div Growth 1Y

+52.00%

EarningsView details →

EPS (Actual)

$0.98

EPS Surprise

9.50%

Beats (12Q)

7/12

Next Q EPS Est

$1.07

Avg Surprise (4Q)

1.64%

Rev Surprise

5.31%

Financials snapshotView financials →

Revenue (TTM)

1.10B

Net Income (TTM)

172.01M

Op. CF (TTM)

249.40M

Next earningsNov 5, 2026 →

Latest newsMore news →

Prestige Brand Holdings recalled 39,060 bottles of Clear Eyes eye drops nationwide due to possible contamination and sterility concerns, as reported by the FDA.30d ago

Prestige Consumer Healthcare Inc. issued $400.0 million of 6.250% Senior Notes due 2034, with interest payable semi-annually starting January 15, 2027, and maturity on July 15, 2034.68d ago

Similar companies

Lung Fung Group Holdings Limited02290.HK 160 Health International Ltd.02656.HK 嘉和美康688246.SH Guanze Medical Information Industry (Holding) Co., Ltd.02427.HK Guardian Pharmacy Services, Inc.GRDN Medlive Technology Co., Ltd.02192.HK Find similar companies →

Latest newsMore news →

Prestige Brand Holdings recalled 39,060 bottles of Clear Eyes eye drops nationwide due to possible contamination and sterility concerns, as reported by the FDA.30d ago Prestige Consumer Healthcare Inc. issued $400.0 million of 6.250% Senior Notes due 2034, with interest payable semi-annually starting January 15, 2027, and maturity on July 15, 2034.68d ago